Civica’s dedication to providing reliable supplies of essential medications is exactly what we need to strengthen supply chains so providers can treat patients without disruption.

Civica’s affordable insulin project will make a real difference for millions of Americans, including those living with T1D, and we are proud to support it. I think it’s going to be transformative.

What the empirical data strongly indicate is that it is not about comparing Civica’s prices with the spot market on a given day but rather, with the longitudinal total mix of prices over time, accounting for longer-term stability and robustness of the supply.

Insulin is a human right and a daily necessity for people with Type 1 diabetes (T1D). Without it they will die. We have an obligation to ensure that all who need insulin can afford it. We are proud to join Civica and other like-minded groups as we all put patients over profit.